background image for GxP Lifeline
GxP Lifeline
  • mc-logo-220x25

    Creating, Staffing and Managing an Inspection War Room

    When I served in the military there was a term used that is still pretty familiar today: "sound general quarters!" When this order was issued, everyone instinctively stopped what they were doing and manned whatever station was theirs during that time. All commands during general quarters came from the war room behind the bridge of the vessel.

    Full story
  • mc-logo-220x25

    Five CAPA Compliance Tips

    Having been intimately involved in how the U.S. Food and Drug Administration (""FDA"") inspects current Good Manufacturing Practice (""cGMP"") requirements for nearly two decades, I find myself repeating certain things to companies. Most often, the issues I repeat relate to Corrective and Preventive Action (""CAPA"") systems. CAPA systems are a focal point in FDA inspections precisely because they are the process that manufacturers follow in case something goes wrong. In the same way that a person'

    Full story
  • MasterControl Logo

    New Report Highlights Need to Reduce R&D Cost

    Most pharmaceutical and biotechnology companies already feel the pressure to reduce their R&D costs. A recent report showing a decline in the ROI for R&D among some of the world's biggest companies is not going to ease the pressure.

    Full story
  • mc-logo-220x25

    What SOPs Do You Need As A Dietary Supplement Distributor?

    If you look at the cGMP regulations for dietary supplements, you'll notice that only one subpart includes the words "holding" or "distributing" in its title. With only 10 or so individual requirements, the aptly-named Subpart M, "Holding and Distributing," is shorter than most. If you're thinking this means there's a much lighter regulatory burden placed on companies that simply hold or distribute dietary supplements than on companies that manufacture them, you'd be right. At the same time, y

    Full story
  • Developing a QMS: Should You Buy or Build?

    When it comes to a quality management system, should you buy or build? Many regulated companies face this dilemma. Perhaps these companies are small startups without a QMS, or maybe they are established but they want to improve their existing systems.

    Full story
  • 2016-bl-what-quality-look-like-20-years

    Clinical Research: Common Challenges in Sponsor-CRO Relationship

    Outsourcing thrives in good times and bad. Life science companies rely on contract research organizations to complement in-house work in times of growth and expansion, but they also rely on CROs to reduce costs in times of financial downturn.

    Full story
  • Can You Use Automated Testing Tools as an FDA-Regulated Company?

    Can you use automated testing tools as an FDA-regulated company?

    Full story
  • mc-logo-220x25

    Surviving the Back Room During an FDA Inspection

    During one of my early inspection experiences with the FDA, I found myself working with a team that felt it didn't need a backroom setup to review documents prior to bringing them to the investigator. Naively, I agreed to let the team move forward with the inspection. As the observer, I watched as things spiraled out of control.

    Full story
  • mc-logo-220x25

    Challenges in Combination Product Regulation

    Combination products raise a variety of regulatory challenges. In addition to the unique technological and scientific challenges these products may raise, when drugs and devices, drugs and biologics or devices and biologics are combined to create a new product, consideration must be given to what regulatory requirements will apply to the combination product as a whole. This article explains the key principles and processes established for the assignment, premarket review, and postmarket regula

    Full story
  • mc-logo-220x25

    Annex 11: The EU's New Expectations for Regulated Computerized Systems

    Note: The views expressed in this article are those of the author and do not necessarily represent those of his/her employer, GxP Lifeline, its editor or MasterControl, Inc.

    Full story
  • mc-logo-220x25

    Writing and Enforcing Your SOPs for GxP Compliance Success

    Writing and developing solid operational procedures is a skill that develops over time. Procedures are usually fairly technical and often describe complex subjects. These procedures are reviewed by subject-matter experts, as well as by internal and external auditors and by employees at all levels of the organization. Therefore, it is important to consider the language used when communicating an idea.

    Full story
  • gxp-default

    Seven Objective-evidence Items the FDA Will Look For

    This article was originally published in the August 2011 edition of EduQuest's publication: EduQuest-ions & Answers.

    Full story
  • mc-logo-220x25

    Transfer, Comparability and Co-validation

    This article provides an overview of the elements of transfer with references to supportive documents that contain more detail on the areas of interest regarding transfer and validation.

    Full story
  • gxp-default

    FREE training from FDA CDRH Learn

    For the medical device industry, it's not always easy to understand and correctly implement FDA regulations. CDRH (Center for Devices and Radiological Health) is providing a free online educational tool with training modules that describe "many aspects of medical device and radiological health regulation [that cover] both premarket and postmarket issues."1

    Full story
  • mc-logo-220x25

    How to Build a Business Case for a Quality Management System

    It is impossible for FDA-regulated manufacturers to conduct business without paying close attention to regulatory compliance.

    Full story
  • mc-logo-220x25

    The Use of "Poka Yoke" with Medical Device Design and Manufacturing

    The Poka Yoke method is something that improves your daily life; why not use it to make your product better, as well? The best solutions are simple, quick to implement and 100 times more effective than a 100-percent final inspection.

    Full story
  • mc-logo-220x25

    Quality Misconceptions

    For over a decade now, I've had the distinct pleasure of talking quality with professionals representing a myriad of industries. For the most part, people who reach me are experiencing a quality-related issue and are looking to quickly extinguish the fire and prevent recurrences. Or they may simply want to reduce their overall risks—and costs—by incorporating a specific quality initiative.

    Full story
  • gxp-default

    What Does 'Readily Available' Mean?

    If you're familiar with 21 CFR Part 11 documentation, you're likely acquainted with compliance audits, electronic record integrity and approval processes. However, you may wonder what the term "readily available" means or what "instantly" refers to in the same context. According to Labcompliance News1, it's these phrases that keep regulated companies guessing.

    Full story
  • m-alone-teal-200x100

    Software Validation & FDA Inspections

    Is your organization ready for an inspection of your Computer System Validation program? In this article, I will offer some key tips on how to prepare for an inspection of your computer system validation (CSV) program. Often times, the FDA comes to inspect your facility for reasons other than your CSV program. However, because so many of our business processes are governed by electronic systems, the topic of Computer System Validation inevitably comes up during the course of an inspection. A

    Full story
  • m-alone-teal-200x100

    Tissue Tracking Failures and Lessons Learned - Hope for the Future

    Note: The opinions expressed by the author in this manuscript are not necessarily representative of the membership of the AATB.

    Full story
[ { "key": "fid#1", "value": ["GxP Lifeline Blog"] } ]